LD2F.02
Embryofetopathy due to oral anticoagulant therapy
Embryofetopathy due to oral anticoagulant therapy
Classification
ICD-11
Chapter
20: Developmental AnomaliesBlock
LD20-LD2ZParent Code
LD2F.0ICD-10 Mapping
1 equivalentWHO Foundation
View on WHOICD-10 Equivalents(1)
ICD-10 Equivalents
View full mappingCorresponding ICD-10-CM codes from the WHO crosswalk mapping
Frequently Asked Questions
What is the ICD-11 code for embryofetopathy due to oral anticoagulant therapy?
The ICD-11 code for embryofetopathy due to oral anticoagulant therapy is LD2F.02. The full clinical description is "Embryofetopathy due to oral anticoagulant therapy".
What does ICD-11 code LD2F.02 mean?
ICD-11 code LD2F.02 represents “Embryofetopathy due to oral anticoagulant therapy”. It is classified under Chapter 20: Developmental Anomalies.
What chapter is LD2F.02 in?
LD2F.02 is in Chapter 20: Developmental Anomalies (codes LA00-LD9Z).
What is the ICD-10 equivalent of ICD-11 code LD2F.02?
LD2F.02 maps to the ICD-10 code: Q86.2 (Dysmorphism due to warfarin). This is an equivalent mapping.
What is the difference between ICD-10 and ICD-11?
ICD-11 is the latest revision of the WHO's International Classification of Diseases, succeeding ICD-10. Key differences include: a fully digital-first design, new chapters for sleep-wake disorders, sexual health, and traditional medicine, improved coding for rare diseases, and better integration with electronic health records through extension codes.
Automate Medical Coding With AI
Send clinical text to the AutoICD API and get back structured ICD-10 and ICD-11 codes with confidence scores. Integrates into any EHR or billing system in minutes.